Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Utility of Standardized Genetic Testing in Kidney Transplant Candidate Evaluation.

Transplantation direct·2026
Same author

A Case of Intermittent Fever a Decade After Renal Transplantation.

Clinical case reports·2026
Same author

Effect of hemodialysis on high-sensitivity cardiac troponin T levels in patients with hypervolemia.

Frontiers in nephrology·2026
Same author

Sodium Intake Estimation in Chronic Kidney Disease: From Measurement Methods to Clinical Outcomes.

Turkish journal of nephrology·2025
Same author

The Impact of Volume Removal by Hemodialysis on Elevated NT-proBNP Levels in Patients With Hypervolemia.

Cureus·2025
Same author

The cognitive burden of epilepsy: Assessing executive dysfunction in adult patients.

Applied neuropsychology. Adult·2025

Related Experiment Video

Updated: Jul 15, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Doxycycline: a pilot study to reduce diabetic proteinuria.

Afsoon Emami Naini1, Ali Amini Harandi, Javad Moghtaderi

  • 1Division of Nephrology, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran.

American Journal of Nephrology
|April 13, 2007
PubMed
Summary

Low-dose doxycycline significantly reduced proteinuria in diabetic nephropathy patients over two months. This matrix metalloproteinase (MMP) inhibitor shows promise for managing diabetic kidney disease, though long-term effects require further study.

Related Experiment Videos

Last Updated: Jul 15, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Area of Science:

  • Nephrology
  • Pharmacology
  • Diabetology

Background:

  • Diabetic proteinuria is linked to matrix metalloproteinase (MMP) activity.
  • Matrix metalloproteinases (MMPs) enzymes contribute to extracellular matrix protein deposition.
  • Doxycycline is a nonselective MMP inhibitor with potential therapeutic applications.

Purpose of the Study:

  • To evaluate doxycycline's efficacy in reducing proteinuria in diabetic patients.
  • To assess the impact of a potent MMP inhibitor on diabetic nephropathy.

Main Methods:

  • A self-control clinical trial involving 35 patients with diabetic nephropathy.
  • Oral doxycycline (100 mg/day) administered for 2 months.
  • Measurement of 24-hour urine protein excretion at baseline, during treatment, and post-discontinuation.

Main Results:

  • Proteinuria significantly decreased by 2 months of doxycycline treatment (p < 0.001).
  • Mean 24-hour urine protein reduced from 888 mg to 643 mg.
  • Proteinuria levels returned to baseline after treatment cessation, with no significant changes in vital signs or blood chemistry.

Conclusions:

  • Low-dose doxycycline therapy effectively reduces proteinuria in diabetic nephropathy over 2 months.
  • Further research is needed to determine optimal dosage and duration for long-term efficacy.
  • Doxycycline presents a potential novel therapeutic strategy for managing diabetic kidney disease.